Provided by Tiger Trade Technology Pte. Ltd.

Bank of Montreal

165.70
-0.6000-0.36%
Post-market: 165.700.00000.00%19:59 EDT
Volume:2.41M
Turnover:401.49M
Market Cap:115.18B
PE:18.94
High:167.38
Open:165.78
Low:164.80
Close:166.30
52wk High:187.22
52wk Low:119.84
Shares:695.09M
Float Shares:694.28M
Volume Ratio:4.60
T/O Rate:0.35%
Dividend:4.77
Dividend Rate:2.88%
EPS(TTM):8.75
EPS(LYR):8.18
ROE:10.57%
ROA:0.62%
PB:1.93
PE(LYR):20.26

Loading ...

CIBC downgrades Bank of Montreal on valuation after rally

TIPRANKS
·
Aug 19

BMO Capital Initiates Perspective Therapeutics at Outperform

MT Newswires Live
·
Aug 19

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 19

Alnylam Pharmaceuticals Initiated at Outperform by BMO Capital

Dow Jones
·
Aug 19

Amapa Minerals initiated with an Outperform at BMO Capital

TIPRANKS
·
Aug 19

BMO’s Brian Quast Initiates Buy on Amapá Minerals, Highlighting Deep Valuation Discount and Long-Life Gold Asset Upside

TIPRANKS
·
Aug 19

BMO starts BioMarin at Outperform, sees slower fade for Voxzogo

TIPRANKS
·
Aug 19

BMO Capital starts Alnylam at Outperform, sees attractive valuation

TIPRANKS
·
Aug 19

BMO starts Prime Medicine at Outperform into 2027 readouts

TIPRANKS
·
Aug 19

BMO starts Bicara at Outperform, sees meaningful upside potential

TIPRANKS
·
Aug 19

BMO Capital starts Ionis at Market Perform pending better visibility

TIPRANKS
·
Aug 19

BMO starts Exelixis at Market Perform into patent cliff

TIPRANKS
·
Aug 19

BMO starts Aktis at Outperform, says opportunities not captured in valuation

TIPRANKS
·
Aug 19

BMO starts Ascendis at Outperform on further platform growth

TIPRANKS
·
Aug 19

Fireweed Metals price target lowered to C$5.25 from C$5.50 at BMO Capital

TIPRANKS
·
Aug 18

Gartner Price Target Cut to $206.00/Share from $214.00 by BMO Capital

Dow Jones
·
Aug 18

Wesdome Gold Mines downgraded to Market Perform from Outperform at BMO Capital

TIPRANKS
·
Aug 18

Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital

TIPRANKS
·
Aug 18

BMO Capital Reaffirms Their Buy Rating on Gilead Sciences (GILD)

TIPRANKS
·
Aug 18

AbCellera Biologics (ABCL) Gets a Buy from BMO Capital

TIPRANKS
·
Aug 18